期刊文献+

肾康灵对阿霉素肾病大鼠尿蛋白质组学的影响 被引量:5

Impact of Shenkangling( 肾康灵) on the Urinary Proteomics of Adriamycin Nephropathy Model Rats
原文传递
导出
摘要 目的探讨原发性肾病综合征的诊断标志物和中药肾康灵药物治疗靶点。方法将50只SD大鼠随机分为正常组、模型组、泼尼松组、中西药组、肾康灵组各10只。除正常组外其余各组大鼠于实验第1天按5.5 mg/kg剂量一次性尾静脉注射阿霉素建立阿霉素肾病大鼠模型。造模后1周,正常组和模型组上、下午各灌服蒸馏水3 ml;泼尼松组上午灌服泼尼松悬液5.5 mg/kg,下午经灌服蒸馏水3 ml;肾康灵组上午灌服肾康灵煎剂1.5 g/100 g,下午经胃灌服蒸馏水3 ml;中西药组上午灌服泼尼松悬液5.5 mg/kg,下午经胃灌服肾康灵煎剂1.5 g/100 g。各组均连续灌胃22天后收集大鼠尿液,利用i TRAQ定量分析技术联合质谱分析法鉴定各组差异蛋白。结果模型组与正常组大鼠的显著差异蛋白3个,其中高表达的蛋白是afamin,isoform CRA_a,低表达的蛋白是gro和Cystatin related protein 2。中西药组与模型组比较,显著差异表达的蛋白有6个,其中高表达的蛋白是apolipoprotein A-Ⅱ,Apolipoprotein A-Ⅳ,Vitronectin,osteopontin,Coagulation factorⅫ,低表达的蛋白是afamin,isoform CRA_a。肾康灵组与模型组比较,显著差异表达的蛋白有6个,其中高表达的蛋白是apolipoprotein A-Ⅱ,Complement factor B,Vitronectin,osteopontin,Coagulation factorⅫ,低表达的蛋白是afamin,isoform CRA_a。结论 gro、Cystatin related protein 2、afamin,isoform CRA_a可作为原发性肾病综合征的诊断标志物,afamin,isoform CRA_a、apolipoprotein A-Ⅱ、Complement factor B、Vitronectin,osteopontin、Coagulation factorⅫ可作为肾康灵的药物治疗靶点。 Objective To explore the diagnostic marker of primary nephrotic syndrome( PNS) and the therapeutic target of Shenkangling( 肾康灵) decoction. Methods Fifty SD rats were randomized into normal group,model group,prednisone group,the herb-western medicine group and the Shenkangling group,10 in each group. Except for the normal group rats in other groups were injected adriamycin 5. 5 mg / kg by tail vein on the first day of the test to establish adriamycin nephropathy rats models. One week after modeling,the normal group and the model group were given 3 ml distilled water in the morning and in the afternoon respectively by gavage. The prednisone group was given prednisone suspension 5. 5 mg / kg in the morning by gavage,3ml distilled water in the afternoon. The Shenkangling group was given Shenkangling decoction 1. 5 g /100 g in the morning by gavage,3ml distilled water in the afternoon. The herb-western medicine group was given prednisone suspension 5. 5 mg / kg in the morning by gavage,Shenkangling decoction 1. 5 g /100 g in the afternoon. After 22 days,urine was collected and differential proteins in all groups were examined by isobaric tags for relative and absolute quantitation( i TRAQ) quantitative analysis technology combined with mass spectrometric method. Results There were three significantly differential proteins in the model group and the normal group,including highly expressed protein afamin,isoform CRA_ a,as well as lowly expressed proteins gro and Cystatin related protein 2. Compared the herb-western medicine group with the model group,there were six significantly differential proteins,including highly expressed proteins apolipoprotein A-Ⅱ,Apolipoprotein A-Ⅳ,Vitronectin,osteopontin and Coagulation factor Ⅻ,as well as lowly expressed protein afamin,isoform CRA_ a. Compared the Shenkangling group with the model group,there were six significantly differential proteins,including highly expressed proteins apolipoprotein A-Ⅱ,Complement factor B,Vitronectin,osteopontin and Coagulation factor Ⅻ,as well as lowly expressed protein afamin,isoform CRA_ a. Conclusion Gro,Cystatin related protein 2,afamin and isoform CRA_ a might be used as the diagnostic markers of PNS. Afamin,isoform CRA_ a,apolipoprotein A-Ⅱ,Complement factor B,Vitronectin,osteopontin and Coagulation factor Ⅻ might be used as the therapeutic target of Shenkangling.
出处 《中医杂志》 CSCD 北大核心 2016年第7期610-614,共5页 Journal of Traditional Chinese Medicine
基金 国家自然科学基金(81173434)
关键词 原发性肾病综合征 肾康灵 阿霉素肾病 蛋白质组学 primary nephrotic syndrome Shenkangling adriamycin nephropathy proteomics
  • 相关文献

参考文献14

  • 1儿童常见肾脏疾病诊治循证指南(一):激素敏感、复发/依赖肾病综合征诊治循证指南(试行)[J].中华儿科杂志,2009,47(3):167-170. 被引量:347
  • 2郑健,曾章超,翁端怡,吴群力.中西医结合治疗小儿频复发性肾病30例的临床观察[J].中国中西医结合杂志,2001,21(8):572-572. 被引量:4
  • 3LEE VW,HARRIS DC.Adriamycin nephropathy:a model of focal segmental glomerulosclerosis[J].Nephrology(Carlton),2011,16(1):30-38.
  • 4DEVARAJAN P.Proteomics for the investigation of acute kidney injury[J].Contrib Nephrol,2008,160:1-16.doi:10.1159/000125893.
  • 5BELLEI E,CUOGHI A,MONARI E,et al.Proteomic analysis of urine in medication-overuse headache patients:possible relation with renal damages[J].J Headache Pain,2012,13(1):45-52.
  • 6FREUE GV,SASAKI M,MEREDITH A,et al.Proteomic signatures in plasma during early acute renal allograft rejection[J].Mol Cell Proteomics,2010,9(9):1954-1967.
  • 7DEVARAJAN P.The use of targeted biomarkers for chronic kidney disease[J].Adv Chronic Kidney Dis,2010,17(6):469-479.
  • 8ANTONELOU MH,KRIEBARDIS AG,VELENTZAS AD,et al.Oxidative stress-associated shape transformation and membrane proteome remodeling in erythrocytes of end stage renal disease patients on hemodialysis[J].J Proteomics,2011,74(11):2441-2452.
  • 9KALANTARI S,NAFAR M,SAMAVAT S,et al.Urinary prognostic biomarkers in patients with focal segmental glomerulosclerosis[J].Nephrourol Mon,2014,6(2):e16806.
  • 10GERHARD DS,WAGNER L,FEINGOLD EA,et al.The status,quality,and expansion of the NIH full-length c DNA project:the Mammalian Gene Collection(MGC)[J].Genome Res,2004,14(10B):2121-2127.

二级参考文献40

  • 1孙嫱,沈颖.Meta分析评价环磷酰胺对儿童肾病综合征的治疗作用[J].中华儿科杂志,2006,44(3):199-201. 被引量:20
  • 2莫樱,陈述枚.肾病综合征频复发及激素依赖的治疗[J].中国实用儿科杂志,2007,22(6):412-416. 被引量:12
  • 3Filler G, Young E, Geier P, et al. Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis ,2003,42 : 1107-1113.
  • 4Eddy AA,Symons JM. Nephrotic syndrome in childhood. Lancet, 2003.362:629-639.
  • 5Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Pedia Child Health,2007,43:337-341.
  • 6易著文.小儿临床肾脏病学//易著文,钟巧.肾病综合征.北京:人民卫生出版社,1998:346-361.
  • 7Koskinies O, Vilska J, Rapola J, et al. Long-term outcome of primary nephrotic syndrome. Arch Dis Child, 1987,57:544-548.
  • 8Tarshish P, Tobin JN, Bwenstein J,et al. Prognostic significance of the early course of minimal change nephrotic syndrome:report of the International Study of Kidney Disease in Children. J Am Soc Nephrol, 1997,8:769-779.
  • 9American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Eur Heart J ,2003,24 : 1965-1991.
  • 10Schrier RW. Disease of the kidney and urinary tract. 8th ed. Philadelphia: Lippincott Williams and Wilkins, 2007: 1585- 1672.

共引文献349

同被引文献38

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部